DK150676A - Fremgangsmade til fremstilling af krystallinsk natrium-o-formyl-cefamandol - Google Patents

Fremgangsmade til fremstilling af krystallinsk natrium-o-formyl-cefamandol

Info

Publication number: DK150676A
Authority: DK; Denmark
Prior art keywords: crystallinic; cefamandol; formyl; sodium; procedure
Prior art date: 1975-04-11

Application number

DK150676A

Other languages

English (en)

Other versions

DK148022C (da

DK148022B (da

Inventor

K S Yang

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1975-04-11

Filing date

1976-03-31

Publication date

1976-10-12

1976-03-31 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1976-10-12 Publication of DK150676A publication Critical patent/DK150676A/da

1985-02-04 Publication of DK148022B publication Critical patent/DK148022B/da

1985-07-22 Application granted granted Critical

1985-07-22 Publication of DK148022C publication Critical patent/DK148022C/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Cephalosporin Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

DK150676A 1975-04-11 1976-03-31 Fremgangsmaade til fremstilling af alfa-formen af krystallinsk natrium-o-formyl-cefamandol DK148022C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US05/567,324 US4006138A (en)	1975-04-11	1975-04-11	Crystalline form of sodium O-formylcefamandole
US56732475		1975-04-11

Publications (3)

Publication Number	Publication Date
DK150676A true DK150676A (da)	1976-10-12
DK148022B DK148022B (da)	1985-02-04
DK148022C DK148022C (da)	1985-07-22

Family

ID=24266692

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK150676A DK148022C (da)	1975-04-11	1976-03-31	Fremgangsmaade til fremstilling af alfa-formen af krystallinsk natrium-o-formyl-cefamandol

Country Status (31)

Country	Link
US (1)	US4006138A (da)
JP (1)	JPS51123812A (da)
AR (1)	AR210880A1 (da)
AT (1)	AT343806B (da)
AU (1)	AU500013B2 (da)
BE (1)	BE840179A (da)
CA (1)	CA1045114A (da)
CH (1)	CH621554A5 (da)
CS (1)	CS191970B2 (da)
DD (1)	DD125950A5 (da)
DE (1)	DE2614669C2 (da)
DK (1)	DK148022C (da)
ES (1)	ES446907A1 (da)
FI (1)	FI65069C (da)
FR (1)	FR2306698A1 (da)
GB (1)	GB1546898A (da)
GR (1)	GR59912B (da)
HU (1)	HU175592B (da)
IL (1)	IL49100A (da)
LU (1)	LU74740A1 (da)
MX (1)	MX3687E (da)
NL (1)	NL184258C (da)
NO (1)	NO151748C (da)
OA (1)	OA05290A (da)
PL (1)	PL104803B1 (da)
PT (1)	PT64917B (da)
RO (1)	RO68501A (da)
SE (1)	SE435290B (da)
SU (1)	SU668608A3 (da)
YU (1)	YU40643B (da)
ZA (1)	ZA761103B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE7503274L (sv) *	1974-04-11	1975-10-13	Ciba Geigy Ag	Cefalosporin
US4085277A (en) *	1975-01-30	1978-04-18	Fujisawa Pharmaceutical Co., Ltd.	7(2-Phenyl or thienyl-2-isonicotinoyloxyacetamido)-3-(1-methyl-1-H tetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic acid
FR2400519A1 (fr) *	1977-08-17	1979-03-16	Roussel Uclaf	Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament
US4168376A (en) *	1978-06-05	1979-09-18	Eli Lilly And Company	Process for crystalline sodium cefamandole
US4946838A (en) *	1981-07-13	1990-08-07	E. R. Squibb & Sons, Inc.	Crystalline anhydrous aztreonam
EP0432297A1 (en) *	1989-12-13	1991-06-19	Technologitschen Kombinat Sa Promischlena Mikrobiologia	A method for the preparation of the sodium salt of O-formyl cefamandole
US5492903A (en) *	1990-06-19	1996-02-20	Takeda Chemical Industries Ltd.	Crystalline esters of (+)-(5R, 6S)-6-[(R)-1-hydroxyethyl]-3-(3-pyridyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]he
US7842791B2 (en) *	2002-12-19	2010-11-30	Nancy Jean Britten	Dispersible pharmaceutical compositions
WO2013057196A1 (en) *	2011-10-20	2013-04-25	Dsm Sinochem Pharmaceuticals Netherlands B.V.	Process for the preparation of cefamandole nafate
CN104530086B (zh) *	2014-12-16	2015-12-09	天津大学	头孢孟多酯钠化合物的新晶型及其结晶制备方法
CN105037392A (zh) *	2015-08-13	2015-11-11	青岛蓝盛洋医药生物科技有限责任公司	一种杀菌药物头孢孟多酯钠化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3887551A (en) *	1964-11-04	1975-06-03	Glaxo Lab Ltd	Crystalline forms of cephaloridine
US3641021A (en) *	1969-04-18	1972-02-08	Lilly Co Eli	3 7-(ring-substituted) cephalosporin compounds

1975
- 1975-04-11 US US05/567,324 patent/US4006138A/en not_active Expired - Lifetime
1976
- 1976-02-24 ZA ZA761103A patent/ZA761103B/xx unknown
- 1976-02-24 GR GR50143A patent/GR59912B/el unknown
- 1976-02-24 CA CA246,497A patent/CA1045114A/en not_active Expired
- 1976-02-25 IL IL49100A patent/IL49100A/xx unknown
- 1976-02-26 SE SE7602565A patent/SE435290B/xx not_active IP Right Cessation
- 1976-02-26 AU AU11435/76A patent/AU500013B2/en not_active Expired
- 1976-03-09 AR AR262491A patent/AR210880A1/es active
- 1976-03-18 PT PT64917A patent/PT64917B/pt unknown
- 1976-03-23 NO NO761017A patent/NO151748C/no unknown
- 1976-03-24 FI FI760788A patent/FI65069C/fi not_active IP Right Cessation
- 1976-03-26 YU YU792/76A patent/YU40643B/xx unknown
- 1976-03-27 OA OA55785A patent/OA05290A/xx unknown
- 1976-03-30 BE BE1007290A patent/BE840179A/xx not_active IP Right Cessation
- 1976-03-31 FR FR7609361A patent/FR2306698A1/fr active Granted
- 1976-03-31 DK DK150676A patent/DK148022C/da not_active IP Right Cessation
- 1976-04-01 RO RO7685381A patent/RO68501A/ro unknown
- 1976-04-01 JP JP51036673A patent/JPS51123812A/ja active Granted
- 1976-04-05 DE DE2614669A patent/DE2614669C2/de not_active Expired
- 1976-04-06 CS CS762264A patent/CS191970B2/cs unknown
- 1976-04-07 SU SU762343056A patent/SU668608A3/ru active
- 1976-04-07 GB GB14020/76A patent/GB1546898A/en not_active Expired
- 1976-04-07 NL NLAANVRAGE7603660,A patent/NL184258C/xx not_active IP Right Cessation
- 1976-04-08 AT AT258476A patent/AT343806B/de not_active IP Right Cessation
- 1976-04-09 LU LU74740A patent/LU74740A1/xx unknown
- 1976-04-09 CH CH455376A patent/CH621554A5/de not_active IP Right Cessation
- 1976-04-09 DD DD192287A patent/DD125950A5/xx unknown
- 1976-04-09 HU HU76EI673A patent/HU175592B/hu unknown
- 1976-04-09 MX MX76161U patent/MX3687E/es unknown
- 1976-04-10 ES ES446907A patent/ES446907A1/es not_active Expired
- 1976-04-10 PL PL1976188683A patent/PL104803B1/pl unknown

Also Published As

Publication number	Publication date
AU1143576A (en)	1977-09-01
DE2614669C2 (de)	1984-09-27
FI65069B (fi)	1983-11-30
IL49100A (en)	1979-03-12
GB1546898A (en)	1979-05-31
AT343806B (de)	1978-06-26
HU175592B (hu)	1980-09-28
MX3687E (es)	1981-04-29
AU500013B2 (en)	1979-05-10
NL184258B (nl)	1989-01-02
YU40643B (en)	1986-04-30
ZA761103B (en)	1977-10-26
FR2306698A1 (fr)	1976-11-05
ES446907A1 (es)	1977-09-16
RO68501A (ro)	1981-04-30
CA1045114A (en)	1978-12-26
NL7603660A (nl)	1976-10-13
NO151748B (no)	1985-02-18
IL49100A0 (en)	1976-04-30
FR2306698B1 (da)	1979-10-05
JPS51123812A (en)	1976-10-28
DK148022C (da)	1985-07-22
GR59912B (en)	1978-03-20
PT64917B (en)	1977-08-24
CH621554A5 (da)	1981-02-13
JPS6110474B2 (da)	1986-03-29
NO151748C (no)	1985-06-05
OA05290A (fr)	1981-02-28
SE435290B (sv)	1984-09-17
NO761017L (da)	1976-10-12
SE7602565L (sv)	1976-10-12
US4006138A (en)	1977-02-01
NL184258C (nl)	1989-06-01
CS191970B2 (en)	1979-07-31
FI760788A (da)	1976-10-12
LU74740A1 (da)	1976-11-11
SU668608A3 (ru)	1979-06-15
FI65069C (fi)	1984-03-12
PL104803B1 (pl)	1979-09-29
ATA258476A (de)	1977-10-15
PT64917A (en)	1976-04-01
DE2614669A1 (de)	1976-10-21
DD125950A5 (da)	1977-06-01
DK148022B (da)	1985-02-04
AR210880A1 (es)	1977-09-30
YU79276A (en)	1982-10-31
BE840179A (fr)	1976-09-30

Legal Events

Date	Code	Title	Description
1990-12-24	PBP	Patent lapsed
1996-05-06	PUP	Patent expired

Publication	Publication Date	Title
DK424476A (da)	1977-03-25	Fremgangsmade til fremstilling af svovlholdige organosiliciumforbindelser
DK567376A (da)	1977-06-20	Fremgangsmade til fremstilling af quinazolonderivater
DK593975A (da)	1976-07-16	Fremgangsmade til fremstilling af substituerede perhalogenalkylamidiner
DK107876A (da)	1976-09-15	Fremgangsmade til fremstilling af thiocarbamider
DK535476A (da)	1977-05-29	Fremgangsmade til fremstilling af 7-methoxycephalosporiner
DK528976A (da)	1977-06-04	Fremgangsmade til fremstilling af indazolderivater
DK324176A (da)	1977-01-18	Fremgangsmade til fremstilling af orthoaminobutyrophenonderivater
DK150676A (da)	1976-10-12	Fremgangsmade til fremstilling af krystallinsk natrium-o-formyl-cefamandol
DK298476A (da)	1977-01-05	Fremgangsmade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK137275C (da)	1978-07-17	Fremgangsmaade til fremstilling af 4-oxo-hexahydropyrazinoisoquinolinderivater
DK415576A (da)	1977-04-02	Fremgangsmade til fremstilling af krystallinsk dipilocarpiniumpamoat
DK399976A (da)	1977-03-05	Fremgangsmade til fremstilling af aralkylamider
DK565676A (da)	1977-06-18	Fremgangsmade til fremstilling af klavamderivater
DK343976A (da)	1977-02-02	Fremgangsmade til fremstilling af 5-androsten-17-on-derivater
DK551076A (da)	1977-06-23	Fremgangsmade til fremstilling af trifluormethylthio-derivater af cyproheptadin
DK253676A (da)	1976-12-17	Fremgangsmade til fremstilling af cycloheptathiopenderivater
DK251176A (da)	1976-12-10	Fremgangsmade til fremstilling af cyklopropanolderivater
DK141584C (da)	1980-10-06	Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere
DK424676A (da)	1977-03-27	Fremgangsmade til fremstilling af 2-alkylindan
DK480676A (da)	1977-04-24	Fremgangsmade til fremstilling af s-alkylphosphordihalogeniddithioater
DK526676A (da)	1977-05-25	Fremgangsmade til fremstilling af 4-chlor-2-butynyl-m-chlorcarbanilat
DK401476A (da)	1977-03-16	Fremgangsmade til fremstilling af benzocycloheptapyridinforbindelser
DK485176A (da)	1977-05-13	Fremgangsmade til fremstilling af pyridylurinstoffer
DK141532C (da)	1980-09-29	Fremgangsmaade til fremstilling af 21-hydroxy-16-pregnen-20-onderivater
DK46476A (da)	1976-08-14	Fremgangsmade til fremstilling af 5-nitrothiazolylimidazolidiner